Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers

Liver Int. 2019 Nov;39(11):2042-2045. doi: 10.1111/liv.14235. Epub 2019 Sep 13.

Abstract

Hepatocyte nuclear factor 1A (HNF1A) maturity-onset diabetes of the young (MODY) is a monogenetic, autosomal dominantly inherited form of diabetes. HNF1A-MODY is associated with HNF1A-inactivated hepatocellular adenoma (H-HCA) formation. Hepatocellular adenoma (HCA) are benign liver tumours and related complications are rare but serious: hepatic haemorrhage and malignant transformation. Guidelines recommend resection of all HCA in men and do not take any co-occurring metabolic disorders into account. We report a family with HCA preceding diabetes mellitus. Male index patient presented with numerous, irresectable HCA. After initial diagnostic and aetiologic uncertainty HNF1A germline mutation c.815G>A (p.Arg272His) was confirmed 8 years later. No HCA-related complications occurred. His diabetic mother was diagnosed with HCA after severe hepatic haemorrhage years before. HNF1A-MODY should be considered in (non-)diabetic (male) patients with H-HCA. We advocate liver biopsy and, if necessary, genetic analysis to precede any intervention for HCA in males and screening for HCA in HNF1A-MODY patients.

Keywords: HNF1A-MODY; hepatocellular adenoma; liver adenomatosis; treatment algorithm.

Publication types

  • Case Reports

MeSH terms

  • Adenoma, Liver Cell / diagnosis
  • Adenoma, Liver Cell / genetics*
  • Adult
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / genetics*
  • Family Health
  • Genetic Testing
  • Hepatocyte Nuclear Factor 1-alpha / genetics*
  • Humans
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / genetics*
  • Male
  • Mutation

Substances

  • HNF1A protein, human
  • Hepatocyte Nuclear Factor 1-alpha

Supplementary concepts

  • Mason-Type Diabetes